78 results
8-K
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
limitation statements regarding the potential, safety, efficacy, and regulatory and clinical progress of, and our business strategy and plans for, our
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
, Chief Executive Officer and President of Rhythm. “This financing is expected to provide the capital we need to execute our corporate strategy through … , including without limitation statements regarding the potential, safety, efficacy, and regulatory and clinical progress of, and our business strategy
8-K
EX-99.1
1raxwl
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-99.1
q99jfz ib
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
snfu1ec2
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
4vn8filmmsx tntd
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
2jx u0qv7
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am
424B5
fh68kvr9b alf0
15 Sep 22
Prospectus supplement for primary offering
4:00pm
424B5
qhtk6l mn
14 Sep 22
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
gzes ni9jl
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am